Cargando…
Senescent cancer cell-derived nanovesicle as a personalized therapeutic cancer vaccine
The development of therapeutic cancer vaccines (TCVs) that provide clinical benefits is challenging mainly due to difficulties in identifying immunogenic tumor antigens and effectively inducing antitumor immunity. Furthermore, there is an urgent need for personalized TCVs because only a limited numb...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073290/ https://www.ncbi.nlm.nih.gov/pubmed/36854774 http://dx.doi.org/10.1038/s12276-023-00951-z |